|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 |
| (11) | Number of the document | 2539370 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11714394.1 |
| Date of filing the European patent application | 2011-02-22 | |
| (97) | Date of publication of the European application | 2013-01-02 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2011/000344 |
| Date | 2011-02-22 |
| (87) | Number | WO 2011/104604 |
| Date | 2011-09-01 |
| (30) | Number | Date | Country code |
| 307009 P | 2010-02-23 | US |
| (72) |
BLEIN, Stanislas, CH
HOU, Samuel, CH
SKEGRO, Darko, CH
|
| (73) |
SANOFI,
54, rue La Boétie, 75008 Paris,
FR
|
| (54) | ANTI-ALPHA2 INTEGRIN ANTIBODIES AND THEIR USES |
| ANTI-ALPHA2 INTEGRIN ANTIBODIES AND THEIR USES |